Clinical analysis of interstitial pneumonia after surgery for lung cancer.
Clinical analysis of interstitial pneumonia after surgery for lung cancer.
复制标题
肺癌术后间质性肺炎的临床分析
DOI:
10.1007/s11748-004-0063-6
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
H. Yokomise
中科院分区:
文献类型:
--
作者:
T. Okamoto;M. Gotoh;D. Masuya;T. Nakashima;Dage Liu;K. Kameyama;S. Ishikawa;Yasumichi Yamamoto;Cheng‐long Huang;H. Yokomise
OBJECTIVE
The postoperative development or exacerbation of interstitial pneumonia (IP) in lung cancer patients often affects prognoses. We analyzed the patients who suffered from IP after surgery, to determine treatment and prevention of IP.
METHODS
One hundred and one consecutive patients who underwent resection were enrolled in the study. Clinical background and post-, perioperative course were compared between patients who developed IP and those who did not.
RESULTS
If IP developed or was exacerbated, steroid pulse (SP) therapy, immunosuppressant (IS) therapy or nitric oxide (NO) inhalation therapy was employed. Of 101 patients, 20 had suffered from IP before surgery. In four of these 20 (20%), postoperative exacerbation was observed. SP therapy was given to all patients. To one patient, IS and NO therapy were added. Three of the four patients died. 81 patients did not have IP; three of them (3.7%) developed IP after the operation and were treated with SP therapy. To one patient, IS and NO therapy were added. Two of the three patients died. IP development or exacerbation after surgery was observed in seven of 101 patients, and five of them died. It was significantly more frequent in patients with poorly differentiated squamous cell carcinoma, restrictive change in pulmonary function tests, and a low percentage diffusion capacity for carbon monoxide. Postoperative development or exacerbation was observed in patients who had undergone lobectomy or pneumonectomy.
CONCLUSIONS
Postoperative IP is a serious complication. Further studies are needed to determine definitive therapeutic options. For the patients with the aforementioned risk factors, limited surgery must be considered.
DOI:
10.1164/ajrccm/151.4.1180
发表时间:
1995
期刊:
American journal of respiratory and critical care medicine.
影响因子:
--
作者:
Cherniack,RM;Colby,TV;Flint,A;Thurlbeck,WM;WaldronJr,JA;Ackerson,L;Schwarz,MI;KingJr,TE
通讯作者:
KingJr,TE